Pharmaceutical

LabVantage Solutions Applauded by Frost & Sullivan for Its Industry-leading Flexible, Scalable, and Cost-effective LIMS Solutions

LabVantage Solutions' strategic expansion and robust internal capabilities position it as a leader in the laboratory informatics market, driving advancements…

3 months ago

N=1 Collaborative Welcomes Hugh Hempel as Executive Director to Lead the Next Phase of Growth

Industry veteran brings expertise to scale patient access to life-changing individualized therapiesBOSTON, MA / ACCESSWIRE / October 3, 2024 /…

3 months ago

Alife’s AI Technology Now Available on Hamilton Thorne Laser Systems

The partnership between Hamilton Thorne, Inc. & Alife Health aims to expand access to cutting-edge AI technology to support clinical…

3 months ago

Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice

LONDON, Oct. 3, 2024 /PRNewswire/ -- Today, Coronado Research announced the engagement of Rob Nichols to support the build-out of…

3 months ago

180 Life Sciences Corp. – Corporate Updates

Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance SheetPALO ALTO, CA /…

3 months ago

Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development

Drug Development & Delivery Publishes Overview of Obesity Formulation Development Results Demonstrating Significant Transdermal Penetration Using Invisicare Technology LAS VEGAS,…

3 months ago

AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Robert Edwards, MD, UPMC, Magee-Womens Hospital Robert Edwards, MD, UPMC, Magee-Womens Hospital Thomas Equels, CEO of AIM ImmunoTech Inc Thomas…

3 months ago

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage…

3 months ago

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration…

3 months ago

NMS Capital Portfolio Company Surplus Solutions Expands Internationally; Announces Partnership with FAMECO Group ApS

NEW YORK and STRASBOURG, France, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of…

3 months ago